Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

RBC Maintains Bullish Stance on J&J

Guavy AI Editorial Team
Instruments
JNJ
Share

RBC Capital analyst Shagun Singh has reaffirmed an Outperform rating on Johnson & Johnson (NYSE:JNJ), maintaining the price target at $287. This decision reflects a steady valuation outlook for the healthcare conglomerate.

The price target of $287 remains unchanged, and the Outperform rating is sustained, indicating continued confidence in the company's performance. Singh's analysis suggests that the stock will continue to outperform its sector peers.

More on Stocks

Stocks just now

Chevron Surges as Global Oil Prices Soar After US Strike

Stocks just now

Visa, Mastercard, Fiserv Team Up to Write Rules for AI Agent Payments

Stocks 1m ago

Venezuela Signs Deals with Chevron, Exxon Mobil, and GeoPark Amid Oil Production Boom

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy